{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:34:12Z","timestamp":1777782852032,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"am","delay-in-days":304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.josat.2024.209524","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T01:06:48Z","timestamp":1727399208000},"page":"209524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkage"],"prefix":"10.1016","volume":"167","author":[{"given":"Brittany B.","family":"Dennis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda","family":"Babe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Gayowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tea","family":"Rosic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myanca","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paxton","family":"Bach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Samet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aijaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.josat.2024.209524_bb0005","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3748\/wjg.v21.i8.2269","article-title":"Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview","volume":"21","author":"Adinolfi","year":"2015","journal-title":"World Journal of Gastroenterology"},{"issue":"12","key":"10.1016\/j.josat.2024.209524_bb0010","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/cid\/ciz693","article-title":"Low hepatitis C reinfection following direct-acting antiviral therapy among people who inject drugs on opioid agonist therapy","volume":"70","author":"Akiyama","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1016\/j.josat.2024.209524_bb0015","article-title":"Role of primary care providers in hepatitis C prevention and care: One step away from evidence-based practice","volume":"60","author":"Artenie","year":"2014","journal-title":"Canadian Family Physician"},{"issue":"8","key":"10.1016\/j.josat.2024.209524_bb0020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.meg.0000280175.79379.04","article-title":"Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: A prospective multicentre study","volume":"19","author":"Belfiori","year":"2007","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"4","key":"10.1016\/j.josat.2024.209524_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dld.2008.08.009","article-title":"Peginterferon plus ribavirin for chronic hepatitis C in opiate addicts on methadone\/buprenorphine maintenance therapy","volume":"41","author":"Belfiori","year":"2009","journal-title":"Digestive and Liver Disease"},{"issue":"10","key":"10.1016\/j.josat.2024.209524_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies conducted using observational routinely-collected health data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1016\/j.josat.2024.209524_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ADM.0b013e318190f0e7","article-title":"Disparities in health services for HIV\/AIDS, hepatitis C virus, and sexually transmitted infections: role of substance abuse treatment programs","volume":"3","author":"Brown","year":"2009","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2024.209524_bb0040","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/cid\/cit271","article-title":"Models of care for the management of hepatitis C virus among people who inject drugs: One size does not fit all","volume":"57 Suppl 2(Suppl 2)","author":"Bruggmann","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"10.1016\/j.josat.2024.209524_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035996","article-title":"Sick leave and disability pension in patients with chronic hepatitis C compared with a matched general population: A nationwide register study","volume":"10","author":"B\u00fcsch","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.josat.2024.209524_bb0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsat.2016.01.009","article-title":"Hepatitis C virus testing and treatment among persons receiving buprenorphine in an office-based program for opioid use disorders","volume":"66","author":"Carey","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209524_bb0055","series-title":"(Source: CDC WONDER). National drug-involved overdose deaths, number among all ages, by gender, 1999\u20132021","author":"CDC Wonder","year":"2021"},{"issue":"8","key":"10.1016\/j.josat.2024.209524_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.19600","article-title":"Patient-reported goals of youths in Canada receiving medication-assisted treatment for opioid use disorder","volume":"4","author":"Chai","year":"2021","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2024.209524_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107917","article-title":"The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study","volume":"209","author":"Dennis","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209524_bb0070","article-title":"Sex-specific risk factors and health disparity among hepatitis C positive patients receiving pharmacotherapy for opioid use disorder: Findings from a propensity matched analysis","author":"Dennis","year":"2021","journal-title":"Journal of Addiction Medicine"},{"issue":"29","key":"10.1016\/j.josat.2024.209524_bb0075","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.3748\/wjg.v27.i29.4818","article-title":"New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years","volume":"27","author":"Dennis","year":"2021","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"10.1016\/j.josat.2024.209524_bb0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-2005-864779","article-title":"Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV\/human immunodeficiency virus coinfection","volume":"25","author":"Dore","year":"2005","journal-title":"Seminars in Liver Disease"},{"issue":"5","key":"10.1016\/j.josat.2024.209524_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3999(00)00155-0","article-title":"Depression, fatigue, and functional disability in patients with chronic hepatitis C","volume":"49","author":"Dwight","year":"2000","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1016\/j.josat.2024.209524_bb0090","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1086\/427441","article-title":"Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users","volume":"40 Suppl 5(Suppl 5)","author":"Edlin","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1016\/j.josat.2024.209524_bb0095","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MLR.0b013e318245a754","article-title":"The accuracy of administrative data for identifying the presence and timing of admission to intensive care units in a Canadian province","volume":"50","author":"Garland","year":"2012","journal-title":"Medical Care"},{"issue":"1","key":"10.1016\/j.josat.2024.209524_bb0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/add.14393","article-title":"Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs","volume":"114","author":"Grebely","year":"2019","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2024.209524_bb0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13722-022-00340-3","article-title":"Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016\u20132018","volume":"17","author":"Gupta","year":"2022","journal-title":"Addiction Science & Clinical Practice"},{"issue":"4","key":"10.1016\/j.josat.2024.209524_bb0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.14745\/ccdr.v48i04a08","article-title":"Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: A cross-sectional study","volume":"48","author":"Konstantelos","year":"2022","journal-title":"Canada Communicable Disease Report"},{"issue":"4","key":"10.1016\/j.josat.2024.209524_bb0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000104884","article-title":"Hepatitis C treatment of opioid dependants receiving maintenance treatment: Results of a Norwegian pilot study","volume":"13","author":"Krook","year":"2007","journal-title":"European Addiction Research"},{"issue":"8","key":"10.1016\/j.josat.2024.209524_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201120","article-title":"Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study","volume":"13","author":"Lapointe-Shaw","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.josat.2024.209524_bb0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1666841","article-title":"The Micro-elimination approach to eliminating hepatitis C: Strategic and operational considerations","volume":"38","author":"Lazarus","year":"2018","journal-title":"Seminars in Liver Disease"},{"issue":"2","key":"10.1016\/j.josat.2024.209524_bb0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3138\/canlivj.2019-0021","article-title":"Impact of comprehensive care on health care use among a cohort of marginalized people living with hepatitis C in Toronto","volume":"3","author":"Mandel","year":"2019","journal-title":"Canadian Liver Journal"},{"issue":"12","key":"10.1016\/j.josat.2024.209524_bb0135","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1046\/j.1360-0443.1998.9312185711.x","article-title":"The Maudsley Addiction Profile (MAP): A brief instrument for assessing treatment outcome","volume":"93","author":"Marsden","year":"1998","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2024.209524_bb0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.20279","article-title":"A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance","volume":"40","author":"Mauss","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.josat.2024.209524_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108438","article-title":"Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings","volume":"131","author":"Ngo","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209524_bb0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.forsciint.2015.01.004","article-title":"Evaluation of poly-drug use in methadone-related fatalities using segmental hair analysis","volume":"248","author":"Nielsen","year":"2015","journal-title":"Forensic Science International"},{"issue":"6","key":"10.1016\/j.josat.2024.209524_bb0155","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1360-0443.2008.02188.x","article-title":"Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients","volume":"103","author":"Novick","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2024.209524_bb0160","series-title":"Government response to the report of the standing committee on health entitled","author":"Parliment of Canada. House of Commons","year":"2016"},{"issue":"11","key":"10.1016\/j.josat.2024.209524_bb0165","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.drugpo.2015.04.015","article-title":"An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential","volume":"26","author":"Perlman","year":"2015","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2024.209524_bb0170","series-title":"Apparent opioid and stimulant toxicity deaths surveillance of opioid and stimulant-related harms in Canada (January 2016\u2013March 2023)","author":"Public Health Agency of Canada","year":"2023"},{"key":"10.1016\/j.josat.2024.209524_bb0175","series-title":"Federal, provincial, and territorial Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid- and Stimulant-related Harms in Canada","author":"Public Health Agency of Canada","year":"2024"},{"key":"10.1016\/j.josat.2024.209524_bb0180","series-title":"Federal, provincial, and territorial special advisory committee on the epidemic of opioid overdoses. opioid- and stimulant-related harms in Canada","author":"Public Health Agency of Canada","year":"2024"},{"key":"10.1016\/j.josat.2024.209524_bb0185","series-title":"Interactive Opioid Tool","article-title":"Opioid-related mobidity and mortality in Ontario","author":"Public Health Ontario","year":"2024"},{"issue":"7","key":"10.1016\/j.josat.2024.209524_bb0190","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/cid\/ciaa105","article-title":"Concurrent initiation of hepatitis C and opioid use disorder treatment in people who inject drugs","volume":"71","author":"Rosenthal","year":"2020","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.josat.2024.209524_bb0195","article-title":"Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: A pilot study","volume":"1503","author":"Samaan","year":"2014","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"2","key":"10.1016\/j.josat.2024.209524_bb0200","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1590\/1516-4446-2019-0734","article-title":"The future of precision medicine in opioid use disorder: Inclusion of patient-important outcomes in clinical trials","volume":"43","author":"Sanger","year":"2021","journal-title":"Brazilian Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2024.209524_bb0205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.21037\/hbsn-21-507","article-title":"Hepatitis C treatment in patients with substance use disorder: The faster the better","volume":"11","author":"Saviano","year":"2022","journal-title":"Hepatobiliary Surgery and Nutrition"},{"issue":"8","key":"10.1016\/j.josat.2024.209524_bb0210","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jclinepi.2005.11.015","article-title":"Administrative data accurately identified intensive care unit admissions in Ontario","volume":"59","author":"Scales","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1016\/j.josat.2024.209524_bb0215","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/hep.21791","article-title":"Hepatitis C treatment in \u201cdifficult-to-treat\u201d psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects","volume":"46","author":"Schaefer","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.josat.2024.209524_bb0220","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1360-0443.2009.02509.x","article-title":"Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy","volume":"104","author":"Sch\u00e4fer","year":"2009","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.josat.2024.209524_bb0225","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cgh.2019.04.035","article-title":"Prevalence of spontaneous clearance of hepatitis C virus infection doubled from 1998 to 2017","volume":"18","author":"Seo","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"4","key":"10.1016\/j.josat.2024.209524_bb0230","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3138\/canlivj-2020-0041","article-title":"Comparison of public and private payments for direct-acting antivirals (DAAs) across Canada","volume":"4","author":"Shakeri","year":"2021","journal-title":"Canadian Liver Journal"},{"issue":"4","key":"10.1016\/j.josat.2024.209524_bb0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/003335491513000411","article-title":"Drug overdose deaths: Let\u2019s get specific","volume":"130","author":"Slavova","year":"2015","journal-title":"Public Health Reports"},{"issue":"3","key":"10.1016\/j.josat.2024.209524_bb0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0376-8716(00)00144-7","article-title":"Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment","volume":"61","author":"Stein","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209524_bb0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1472-6963-7-39","article-title":"Drug treatment program patients\u2019 hepatitis C virus (HCV) education needs and their use of available HCV education services","volume":"7","author":"Strauss","year":"2007","journal-title":"BMC Health Services Research"},{"issue":"4","key":"10.1016\/j.josat.2024.209524_bb0250","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jurban\/jth153","article-title":"Co-occurring hepatitis C, substance use, and psychiatric illness: Treatment issues and developing integrated models of care","volume":"81","author":"Sylvestre","year":"2004","journal-title":"Journal of Urban Health"},{"issue":"3","key":"10.1016\/j.josat.2024.209524_bb0255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jsat.2005.06.002","article-title":"The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone","volume":"29","author":"Sylvestre","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2024.209524_bb0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3138\/canlivj-2020-0025","article-title":"Prescribing trends in direct-acting antivirals for the treatment of hepatitis C in Ontario, Canada","volume":"4","author":"Tadrous","year":"2021","journal-title":"Canadian Liver Journal"},{"issue":"2","key":"10.1016\/j.josat.2024.209524_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpain.2003.12.005","article-title":"Validation of the brief pain inventory for chronic nonmalignant pain","volume":"5","author":"Tan","year":"2004","journal-title":"The Journal of Pain"},{"issue":"10","key":"10.1016\/j.josat.2024.209524_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Medicine"},{"issue":"6","key":"10.1016\/j.josat.2024.209524_bb0275","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.23220","article-title":"Public health impact of antiviral therapy for hepatitis C in the United States","volume":"50","author":"Volk","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.josat.2024.209524_bb0280","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/ADM.0000000000000147","article-title":"Primary care-based hepatitis C treatment outcomes with first-generation direct-acting agents","volume":"9","author":"Woodrell","year":"2015","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2024.209524_bb0285","author":"World Health Organization"},{"issue":"2","key":"10.1016\/j.josat.2024.209524_bb0290","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jare.2016.09.005","article-title":"Hepatitis C virus infection, and neurological and psychiatric disorders - a review","volume":"8","author":"Yarlott","year":"2017","journal-title":"Journal of Advanced Research"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T06:14:54Z","timestamp":1730614494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924002364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":58,"alternative-id":["S2949875924002364"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209524","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkage","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209524"}}